New FDA Policies Could Limit the Full Value of AI in Medicine
Scott Gottlieb
Abstract
This JAMA Forum discusses the ways in which recent changes to US Food and Drug Administration (FDA) policies related to the regulation of artificial intelligence (AI) have added new uncertainties for the use of AI tools in medicine.
Topics & Concepts
Food and drug administrationValue (mathematics)Limit (mathematics)MedicineDrug approvalAlternative medicineEngineering ethicsPolitical scienceDrugPharmacologyComputer scienceEngineeringMathematicsMachine learningPathologyMathematical analysisHealthcare cost, quality, practicesHealth Systems, Economic Evaluations, Quality of LifeHealth and Medical Research Impacts